| Literature DB >> 16243265 |
Francesco M Veronese1, Gianfranco Pasut.
Abstract
PEGylation defines the modification of a protein, peptide or non-peptide molecule by the linking of one or more polyethylene glycol (PEG) chains. This polymer is non-toxic, non-immunogenic, non-antigenic, highly soluble in water and FDA approved. The PEG-drug conjugates have several advantages: a prolonged residence in body, a decreased degradation by metabolic enzymes and a reduction or elimination of protein immunogenicity. Thanks to these favorable properties, PEGylation now plays an important role in drug delivery, enhancing the potentials of peptides and proteins as therapeutic agents.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16243265 DOI: 10.1016/S1359-6446(05)03575-0
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851